Aclaris reports promising interim data from phase II trial of ATI-501 in severe alopecia areata June 29, 2018
Ziopharm initiates phase I trial of Ad-RTS-hIL-12 plus veledimex with nivolumab in recurrent GBM June 29, 2018
RSS